[To learn English]
Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to Chancellor Friedrich Merz, the latest drugmaker to react to government policy proposals that would lower drug prices.
Pfizer's letter, dated June 9 and seen by Reuters on Wednesday, was first reported by German business newspaper Handelsblatt.
辉瑞正在重新评估其在德国计划投资的时间和规模，CEO 阿尔伯特·布尔拉在致总理弗里德里希·默茨的一封信中表示，这是最新一家对德国政府拟降低药价的政策提案做出反应的制药公司。
这封日期为6月9日的信函于周三被路透社看到，最早由德国商业报纸《商报》报道。
LearnEnglish Leave a remark